126 related articles for article (PubMed ID: 8557319)
1. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
Gowal D; Tahlan AK
Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
[TBL] [Abstract][Full Text] [Related]
2. Immune status of volunteers one year after administration of Japanese encephalitis vaccine produced in India.
Saxena SN; Bhau LN; Singh G; Gowal D; Sood YK; Misra CN; Das BK
Indian J Med Res; 1989 Nov; 89():362-7. PubMed ID: 2559892
[TBL] [Abstract][Full Text] [Related]
3. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
[TBL] [Abstract][Full Text] [Related]
4. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
5. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
[TBL] [Abstract][Full Text] [Related]
6. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M
Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
Kurane I; Takasaki T
Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
[TBL] [Abstract][Full Text] [Related]
9. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
10. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
[TBL] [Abstract][Full Text] [Related]
11. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
13. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
Guo W; Li L; Wu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
[TBL] [Abstract][Full Text] [Related]
14. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.
Muangchana C; Henprasertthae N; Nurach K; Theppang K; Yoocharoen P; Varinsathien P; Techathawat S; Sanohsieng S; Anantapreecha S
Vaccine; 2012 Jan; 30(2):361-7. PubMed ID: 22075090
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data.
Intralawan P; Paupunwatana S
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
[TBL] [Abstract][Full Text] [Related]
18. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
19. Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
Kosalaraksa P; Watanaveeradej V; Pancharoen C; Capeding MR; Feroldi E; Bouckenooghe A
Pediatr Infect Dis J; 2017 Apr; 36(4):e108-e113. PubMed ID: 28030526
[TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
